The IL-1 (β in humans, α in mice) activated the NLRP3 Inflammasome in the tumor microenvironment and induced IL-22 production in various CD4+ T-cells including Th22, Th17, and Th1 cells [103]. This evidence concerns the gene IL22 and neoplasm.